Essex Woodlands Health Ventures

Latest statistics and disclosures from Essex Woodlands Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are MDXG, BVS, TELA, EYPT, MNOV, and represent 99.58% of Essex Woodlands Management's stock portfolio.
  • Reduced shares in these 1 stock: EYPT.
  • Essex Woodlands Management was a net seller of stock by $-2.8M.
  • Essex Woodlands Management has $433M in assets under management (AUM), dropping by 23.64%.
  • Central Index Key (CIK): 0001542339

Tip: Access up to 7 years of quarterly data

Positions held by Essex Woodlands Health Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Essex Woodlands Management

Essex Woodlands Management holds 7 positions in its portfolio as reported in the December 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
MiMedx (MDXG) 62.6 $271M 28M 9.62
 View chart
Bioventus Com Cl A (BVS) 31.6 $137M 13M 10.50
 View chart
Tela Bio (TELA) 2.9 $12M 4.1M 3.02
 View chart
Eyepoint Pharmaceuticals Com New (EYPT) 2.0 $8.7M -24% 1.2M 7.45
 View chart
Medicinova Com New (MNOV) 0.5 $2.3M 1.1M 2.10
 View chart
Revance Therapeutics (RVNC) 0.3 $1.4M 457k 3.04
 View chart
Venus Concept (VERO) 0.1 $414k 1.1M 0.38
 View chart

Past Filings by Essex Woodlands Management

SEC 13F filings are viewable for Essex Woodlands Management going back to 2011

View all past filings